4
Changes in Ownership
Xilio Therapeutics, Inc. Filed Acc 0001104659-23-088350
Options or other derivatives
- Chief Operating Officer acquired 150,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Frankenfield Christopher James · Chief Operating Officer
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2023-08-03 | Grant or award : show line 1 in the form Stock Option (Right to Buy) | +150,000 | 150,000 | D |
Loading xslF345X05/tm2323038-2_4seq1.xml…